Counterfeit Avastin in India: Punish the Criminals, Not the Patients

American Journal of Ophthalmology

Volumn 170, Issue , 2016, Pages 228-231

  Stewart, Michael W ^a   Narayanan, Raja ^b   Gupta, Vishali ^c   Rosenfeld, Philip J ^d   Martin, Daniel F ^e   Chakravarthy, Usha ^f  

^a MAYO CLINIC COLLEGE OF MEDICINE   (United States)

^b L V PRASAD EYE INSTITUTE   (India)

^c POSTGRADUATE INSTITUTE OF MEDICAL EDUCATION AND RESEARCH   (India)

^d UNIVERSITY OF MIAMI MILLER SCHOOL OF MEDICINE   (United States)

^e LERNER RESEARCH INSTITUTE   (United States)

^f QUEEN'S UNIVERSITY BELFAST   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

AFLIBERCEPT; BEVACIZUMAB; COUNTERFEIT DRUG; RANIBIZUMAB; ANGIOGENESIS INHIBITOR; VASCULOTROPIN A; VEGFA PROTEIN, HUMAN;

ARTICLE; DRUG APPROVAL; DRUG BIOAVAILABILITY; DRUG CONTAMINATION; DRUG COST; DRUG SAFETY; DRUG STERILITY; ENDOPHTHALMITIS; FOOD AND DRUG ADMINISTRATION; GUJARAT; HEALTH CARE POLICY; HEALTH INSURANCE; HUMAN; INFORMED CONSENT; OFF LABEL DRUG USE; OFFENDER; PRACTICE GUIDELINE; PRIORITY JOURNAL; ANTAGONISTS AND INHIBITORS; BACTERIAL EYE INFECTION; CHEMICALLY INDUCED; DRUG CONTROL; DRUG FORMULATION; FRAUD; INDIA; INTRAVITREAL DRUG ADMINISTRATION; LEGISLATION AND JURISPRUDENCE; MICROBIOLOGY; PATIENT SAFETY; SUPPLY AND DISTRIBUTION;

ANGIOGENESIS INHIBITORS; BEVACIZUMAB; COUNTERFEIT DRUGS; CRIMINALS; DRUG AND NARCOTIC CONTROL; DRUG COMPOUNDING; ENDOPHTHALMITIS; EYE INFECTIONS, BACTERIAL; FRAUD; HUMANS; INDIA; INTRAVITREAL INJECTIONS; OFF-LABEL USE; PATIENT SAFETY; VASCULAR ENDOTHELIAL GROWTH FACTOR A;

EID: 84992448542     PISSN: 00029394     EISSN: 18791891     Source Type: Journal    
DOI: 10.1016/j.ajo.2016.05.023     Document Type: Article

References (16)

1. 1 Wang, F., Yu, S., Liu, K., et al. Acute intraocular inflammation caused by endotoxin after intravitreal injection of counterfeit bevacizumab in Shanghai, China. Ophthalmology 120:2 (2013), 355–361.
2. 2 Ferrara, N., Damico, L., Shams, N., Lowman, H., Kim, R., Development of ranibizumab, an anti-vascular endothelial growth factor antigen binding fragment, as therapy for neovascular age-related macular degeneration. Retina 26:8 (2006), 859–870.
3. 3 Rosenfeld, P.J., Moshfeghi, A.A., Puliafito, C.A., Optical coherence tomography findings after an intravitreal injection of bevacizumab (Avastin) for neovascular age-related macular degeneration. Ophthalmic Surg Lasers Imaging 36:4 (2005), 331–335.
4. 4 Rosenfeld, P.J., Fung, A.E., Puliafito, C.A., Optical coherence tomography findings after an intravitreal injection of bevacizumab (Avastin) for macular edema from central retinal vein occlusion. Ophthalmic Surg Lasers Imaging 36:4 (2005), 336–339.
5. 5 Brechner, R.J., Rosenfeld, P.J., Babish, J.D., et al. Pharmacotherapy for neovascular age-related macular degeneration: an analysis of the 100% 2008 Medicare fee-for-service part B claims file. Am J Ophthalmol 151:5 (2011), 887–895.
6. 6 Martin, D.F., Maguire, M.G., Ying, G.S., Ranibizumab and bevacizumab for neovascular age-related macular degeneration. N Engl J Med 364:20 (2011), 1897–1908.
7. 7 Chakravarthy, U., Harding, S.P., Rogers, C.A., et al. Alternative treatments to inhibit VEGF in age-related choroidal neovascularisation: 2-year findings of the IVAN randomized controlled trial. Lancet 382:9900 (2013), 1258–1267.
8. 8 Diabetic Retinopathy Clinical Research Network, Wells, J.A., Glassman, A.R., Ayala, A.R., et al. Aflibercept, bevacizumab, or ranibizumab for diabetic macular edema. N Engl J Med 372:13 (2015), 1193–1203.
9. 9 Industry complains to EU over French law pushing cheap eye drug. Available at http://www.reuters.com/article/pharmaceuticals-france-avastin-idUSL5N1173RD20150901. Accessed February 11, 2016.
10. 10 Goldberg, R.A., Flynn, H.W. Jr., Miller, D., Gonzalez, S., Isom, R.F., Streptococcus endophthalmitis outbreak after intravitreal injection of bevacizumab: one-year outcomes and investigative results. Ophthalmology 120:7 (2013), 1448–1453.
11. 11 VanderBeek, B.L., Bonaffini, S.G., Ma, L., Association of compounded bevacizumab with postinjection endophthalmitis. JAMA Ophthalmol 133:10 (2015), 1159–1164.
12. 12 Top 50 pharmaceutical products by global sales. Available at http://www.pmlive.com/top_pharma_list/Top_50_pharmaceutical_products_by_global_sales. Accessed February 24, 2016.
13. 13 How Fake Cancer Drugs Entered U.S. Available at http://www.wsj.com/articles/SB10001424052702303879604577410430607090226. Accessed February 5, 2016.
14. 14 Garcia-Aguirre, G., Vanzinni-Zago, V., Quiroz-Mercado, H., Growth of Scytalidium sp. in a counterfeit bevacizumab bottle. Indian J Ophthalmol 61:9 (2013), 523–525.
15. 15 India's CDSCO Warns Against Using Roche's Avastin as Eye Treatment. Available at http://www.raps.org/Regulatory-Focus/News/2016/01/21/23941/India%E2%80%99s-CDSCO-Warns-Against-Using-Roche%E2%80%99s-Avastin-as-Eye-Treatment/. Accessed February 7, 2016.
16. ®—what have we learned and what can be done?. Nat Rev Clin Oncol 12:5 (2015), 302–308.